M. Lochmann van Bennekom

Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness

F. Zitman, H. Gijsman, M. Lochmann van Bennekom, 2013, Journal of psychopharmacology.

The Additional Effect of Individualized Prescriber-Focused Feedback on General Guideline Instruction in Reducing Antipsychotic Polypharmacy in Inpatients

R. Verkes, H. Gijsman, H. Groenewoud, 2021, Journal of clinical psychopharmacology.

The Process of Change of Mindfulness-Based Cognitive Therapy for People with Bipolar Disorder: a Qualitative Study

A. Speckens, E. Regeer, M. Lochmann van Bennekom, 2020, Mindfulness.

Adverse or therapeutic? A mixed-methods study investigating adverse effects of Mindfulness-Based Cognitive Therapy in bipolar disorder

A. Speckens, E. Regeer, R. Kupka, 2021, PloS one.

The feasibility of mindfulness-based cognitive therapy for people with bipolar disorder: a qualitative study

A. Speckens, E. Regeer, M. Lochmann van Bennekom, 2020, International Journal of Bipolar Disorders.

Mindfulness-based cognitive therapy v. treatment as usual in people with bipolar disorder: A multicentre, randomised controlled trial

A. Speckens, E. Regeer, R. Kupka, 2023, Psychological Medicine.

Development and validation of a Manic Thought Inventory

R. Kupka, A. Speckens, P. T. ten Klooster, 2023, Bipolar disorders.